
Arkus AI is a Stockholm-based startup revolutionizing precision medicine through its Arkus Core platform, which deploys modular, intelligent AI agents to enhance personalized medicine across care, research, and discovery. The platform integrates seamlessly with existing healthcare systems, supporting healthcare providers, pharma, biotech, health-tech companies, and developers. Arkus AI focuses on AI-driven precision medicine with regulatory-aware, interoperable technology designed for real-world deployment. The company combines advanced AI with compassionate healthcare goals, aiming to democratize preventive genetic care and empower individuals and healthcare professionals with cutting-edge digital tools and e-health platforms to improve diagnosis, treatment, and patient outcomes.

Arkus AI is a Stockholm-based startup revolutionizing precision medicine through its Arkus Core platform, which deploys modular, intelligent AI agents to enhance personalized medicine across care, research, and discovery. The platform integrates seamlessly with existing healthcare systems, supporting healthcare providers, pharma, biotech, health-tech companies, and developers. Arkus AI focuses on AI-driven precision medicine with regulatory-aware, interoperable technology designed for real-world deployment. The company combines advanced AI with compassionate healthcare goals, aiming to democratize preventive genetic care and empower individuals and healthcare professionals with cutting-edge digital tools and e-health platforms to improve diagnosis, treatment, and patient outcomes.
Location & focus: Stockholm-based healthtech focused on AI-driven precision medicine and preventive genetic care
Core product: Arkus Core — an agentic AI platform for creating, orchestrating and deploying AI agents across clinical, research and discovery workflows
Initial use case: Tools for genetic/hereditary profiling workflows (intake, pedigree, consent, risk assessment)
Funding & investors: Public innovation grants from Vinnova; investors listed include Propel Capital and Sting; Lars Appelstål named as investor/advisor; total funding reported as 53,565 USD
Founded: 2020
Precision medicine with a focus on genetic and hereditary profiling workflows for healthcare providers, research and discovery.
2020
Hospitals and Health Care
Startup Grant from Vinnova
Vinnova-awarded funding supporting a joint project with Karolinska Institutet and partners
Company announcement of investor funding success (amount not disclosed)
Investors listed in company snapshot
“Includes public innovation grants from Vinnova; investors listed include Propel Capital and Sting; Lars Appelstål is listed as an investor and advisor”
| Company |
|---|
About Arkus AI
Arkus AI is on a mission to revolutionise medicine and healthcare through intelligent, AI-powered technologies. We are developing autonomous AI agents and a robust AI platform to support clinicians, researchers, and healthcare administrators in addressing some of the most complex challenges in medicine.
Role Overview
We are looking for an engineer who can combine GenAI expertise, backend development, and cloud engineering to enhance and scale our Agent Builder platform. You will work hands-on with OpenAI models deployed on Azure , building multi-agent workflows and backend services that enable safe, reliable, healthcare-grade AI systems.
This role sits at the core of our platform team, working on the foundation that lets AI agents build and interact with other AI agents .
What You’ll Do
GenAI & Agent Engineering
Backend Engineering
Collaboration & Product Development
Who You Are
Why Join Arkus.ai?
How to Apply
Send your CV, GitHub/portfolio, and a short intro to:
join @arkus.ai